Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
Clinical trial NCT02813837 · UNKNOWN
Trial details
- NCT number
- NCT02813837
- Sponsor
- Innovative Cellular Therapeutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2021-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.